149 related articles for article (PubMed ID: 8808153)
1. Neonatal MSG reduces hypothalamic DA, beta-endorphin, and delays weight gain in genetically obese (A viable yellow/alpha) mice.
Caputo FA; Ali SF; Wolff GL; Scallet AC
Pharmacol Biochem Behav; 1996 Feb; 53(2):425-32. PubMed ID: 8808153
[TBL] [Abstract][Full Text] [Related]
2. Hyperphagia and weight gain after gold-thioglucose: relation to hypothalamic neuropeptide Y and proopiomelanocortin.
Bergen HT; Mizuno TM; Taylor J; Mobbs CV
Endocrinology; 1998 Nov; 139(11):4483-8. PubMed ID: 9794456
[TBL] [Abstract][Full Text] [Related]
3. MSG effects on beta-endorphin and alpha-MSH in the hypothalamus and caudal medulla.
Alessi NE; Quinlan P; Khachaturian H
Peptides; 1988; 9(4):689-95. PubMed ID: 2852357
[TBL] [Abstract][Full Text] [Related]
4. Effect of neonatal treatment with monosodium glutamate on the secretion of alpha-MSH, beta-endorphin and ACTH in the rat.
Conte-Devolx B; Giraud P; Castanas E; Boudouresque F; Orlando M; Gillioz P; Oliver C
Neuroendocrinology; 1981; 33(4):207-11. PubMed ID: 6270587
[TBL] [Abstract][Full Text] [Related]
5. Postnatal MSG treatment attenuates angiotensin II (AII) induced drinking in rats.
Caputo FA; Scallet AC
Physiol Behav; 1995 Jul; 58(1):25-9. PubMed ID: 7667423
[TBL] [Abstract][Full Text] [Related]
6. Neonatal treatment with monosodium glutamate does not alter grooming behavior induced by novelty or adrenocorticotropic hormone.
Dunn AJ; Webster EL; Nemeroff CB
Behav Neural Biol; 1985 Jul; 44(1):80-9. PubMed ID: 3010931
[TBL] [Abstract][Full Text] [Related]
7. Neonatal monosodium glutamate lesions alter neurosensitivity to ethanol in adult mice.
Crabbe JC; Dorsa DM
Pharmacol Biochem Behav; 1986 May; 24(5):1343-51. PubMed ID: 2941768
[TBL] [Abstract][Full Text] [Related]
8. Hypothalamic neuronal histamine in genetically obese animals: its implication of leptin action in the brain.
Itateyama E; Chiba S; Sakata T; Yoshimatsu H
Exp Biol Med (Maywood); 2003 Nov; 228(10):1132-7. PubMed ID: 14610251
[TBL] [Abstract][Full Text] [Related]
9. Behavioral and neurochemical effects of neonatal administration of monosodium L-glutamate in mice.
Dawson R; Lorden JF
J Comp Physiol Psychol; 1981 Feb; 95(1):71-84. PubMed ID: 7217414
[TBL] [Abstract][Full Text] [Related]
10. Lentivirus-mediated α-melanocyte-stimulating hormone overexpression in the hypothalamus decreases diet induced obesity in mice.
Eerola K; Nordlund W; Virtanen S; Dickens AM; Mattila M; Ruohonen ST; Chua SC; Wardlaw SL; Savontaus M; Savontaus E
J Neuroendocrinol; 2013 Dec; 25(12):1298-1307. PubMed ID: 24118213
[TBL] [Abstract][Full Text] [Related]
11. Neonatal treatment with monosodium glutamate: effects of prolonged growth hormone (GH)-releasing hormone deficiency on pulsatile GH secretion and growth in female rats.
Maiter D; Underwood LE; Martin JB; Koenig JI
Endocrinology; 1991 Feb; 128(2):1100-6. PubMed ID: 1989848
[TBL] [Abstract][Full Text] [Related]
12. Effects of ad libitum ingestion of monosodium glutamate on weight gain in C57BL6/J mice.
Ren X; Ferreira JG; Yeckel CW; Kondoh T; de Araujo IE
Digestion; 2011; 83 Suppl 1():32-6. PubMed ID: 21389726
[TBL] [Abstract][Full Text] [Related]
13. Lack of proopiomelanocortin peptides results in obesity and defective adrenal function but normal melanocyte pigmentation in the murine C57BL/6 genetic background.
Smart JL; Low MJ
Ann N Y Acad Sci; 2003 Jun; 994():202-10. PubMed ID: 12851317
[TBL] [Abstract][Full Text] [Related]
14. Hypothalamic monoamine metabolism in mice: evaluation of drug challenges and neurotoxic insult.
Dawson R; Callahan MF; Annau Z
Pharmacology; 1986; 32(1):25-37. PubMed ID: 2418449
[TBL] [Abstract][Full Text] [Related]
15. Monosodium glutamate-induced reductions in hypothalamic beta-endorphin content result in mu-opioid receptor upregulation in the medial preoptic area.
Desjardins GC; Brawer JR; Beaudet A
Neuroendocrinology; 1992 Sep; 56(3):378-84. PubMed ID: 1331839
[TBL] [Abstract][Full Text] [Related]
16. Hypothalamic POMC neurons promote cannabinoid-induced feeding.
Koch M; Varela L; Kim JG; Kim JD; Hernández-Nuño F; Simonds SE; Castorena CM; Vianna CR; Elmquist JK; Morozov YM; Rakic P; Bechmann I; Cowley MA; Szigeti-Buck K; Dietrich MO; Gao XB; Diano S; Horvath TL
Nature; 2015 Mar; 519(7541):45-50. PubMed ID: 25707796
[TBL] [Abstract][Full Text] [Related]
17. Ontogenesis of proopiomelanocortin and its processing to beta-endorphin by the fetal and neonatal rat brain.
Angelogianni P; Li HL; Gianoulakis C
Neuroendocrinology; 2000 Oct; 72(4):231-41. PubMed ID: 11070427
[TBL] [Abstract][Full Text] [Related]
18. The obesity susceptibility gene Cpe links FoxO1 signaling in hypothalamic pro-opiomelanocortin neurons with regulation of food intake.
Plum L; Lin HV; Dutia R; Tanaka J; Aizawa KS; Matsumoto M; Kim AJ; Cawley NX; Paik JH; Loh YP; DePinho RA; Wardlaw SL; Accili D
Nat Med; 2009 Oct; 15(10):1195-201. PubMed ID: 19767734
[TBL] [Abstract][Full Text] [Related]
19. Adrenalectomy reverses obese phenotype and restores hypothalamic melanocortin tone in leptin-deficient ob/ob mice.
Makimura H; Mizuno TM; Roberts J; Silverstein J; Beasley J; Mobbs CV
Diabetes; 2000 Nov; 49(11):1917-23. PubMed ID: 11078460
[TBL] [Abstract][Full Text] [Related]
20. β-endorphin differentially contributes to food anticipatory activity in male and female mice undergoing activity-based anorexia.
Daimon CM; Hentges ST
Physiol Rep; 2021 Mar; 9(5):e14788. PubMed ID: 33661571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
